ANIP logo

ANI Pharmaceuticals, Inc. (ANIP) Free Cash Flow

Annual FCF:

$47.06M-$53.38M(-53.15%)
December 31, 2024

Summary

  • As of today, ANIP annual free cash flow is $47.06 million, with the most recent change of -$53.38 million (-53.15%) on December 31, 2024.
  • During the last 3 years, ANIP annual free cash flow has risen by +$67.38 million (+331.66%).
  • ANIP annual free cash flow is now -53.15% below its all-time high of $100.45 million, reached on December 31, 2023.

Performance

ANIP Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPcash flow metrics

Quarterly FCF:

$37.89M-$31.01M(-45.01%)
September 30, 2025

Summary

  • As of today, ANIP quarterly free cash flow is $37.89 million, with the most recent change of -$31.01 million (-45.01%) on September 30, 2025.
  • Over the past year, ANIP quarterly free cash flow has increased by +$30.86 million (+438.93%).
  • ANIP quarterly free cash flow is now -45.01% below its all-time high of $68.90 million, reached on June 30, 2025.

Performance

ANIP Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPcash flow metrics

TTM FCF:

$136.04M+$30.86M(+29.34%)
September 30, 2025

Summary

  • As of today, ANIP TTM free cash flow is $136.04 million, with the most recent change of +$30.86 million (+29.34%) on September 30, 2025.
  • Over the past year, ANIP TTM free cash flow has increased by +$62.39 million (+84.72%).
  • ANIP TTM free cash flow is now at all-time high.

Performance

ANIP TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPcash flow metrics

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

ANIP Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-53.1%+438.9%+84.7%
3Y3 Years+331.7%+712.0%+358.3%
5Y5 Years+160.3%+610.5%+425.5%

ANIP Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-53.1%+198.8%-45.0%+602.4%at high+358.3%
5Y5-Year-53.1%+188.7%-45.0%+274.6%at high+321.7%
All-TimeAll-Time-53.1%+138.7%-45.0%+150.8%at high+193.5%

ANIP Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2025
-
$37.89M(-45.0%)
$136.04M(+29.3%)
Jun 2025
-
$68.90M(+355.0%)
$105.18M(+113.6%)
Mar 2025
-
$15.14M(+7.4%)
$49.24M(+3.0%)
Dec 2024
$47.06M(-53.1%)
$14.10M(+100.5%)
$47.78M(-35.1%)
Sep 2024
-
$7.03M(-45.8%)
$73.64M(-21.8%)
Jun 2024
-
$12.96M(-5.3%)
$94.23M(-0.9%)
Mar 2024
-
$13.69M(-65.7%)
$95.06M(-5.4%)
Dec 2023
$100.45M(+310.8%)
$39.96M(+44.7%)
$100.45M(+89.7%)
Sep 2023
-
$27.62M(+100.1%)
$52.95M(+176.6%)
Jun 2023
-
$13.80M(-27.6%)
$19.14M(+356.3%)
Mar 2023
-
$19.07M(+352.9%)
-$7.47M(+84.3%)
Dec 2022
-$47.66M(-134.6%)
-$7.54M(-21.8%)
-$47.66M(+9.5%)
Sep 2022
-
-$6.19M(+51.7%)
-$52.67M(-0.4%)
Jun 2022
-
-$12.80M(+39.4%)
-$52.46M(+14.5%)
Mar 2022
-
-$21.12M(-68.2%)
-$61.37M(-202.1%)
Dec 2021
-$20.32M(+61.7%)
-$12.55M(-109.7%)
-$20.32M(-30.3%)
Sep 2021
-
-$5.99M(+72.4%)
-$15.59M(+8.4%)
Jun 2021
-
-$21.71M(-208.9%)
-$17.03M(-175.0%)
Mar 2021
-
$19.93M(+354.6%)
$22.71M(+142.8%)
Dec 2020
-$53.05M(-393.4%)
-$7.83M(-5.5%)
-$53.05M(-26.9%)
Sep 2020
-
-$7.42M(-141.2%)
-$41.80M(-188.0%)
Jun 2020
-
$18.03M(+132.3%)
-$14.51M(+54.3%)
Mar 2020
-
-$55.84M(-1728.3%)
-$31.76M(-275.6%)
Dec 2019
$18.08M(-67.8%)
$3.43M(-82.7%)
$18.08M(-54.2%)
Sep 2019
-
$19.86M(+2426.8%)
$39.46M(+49.5%)
Jun 2019
-
$786.00K(+113.1%)
$26.39M(-5.6%)
Mar 2019
-
-$5.99M(-124.2%)
$27.94M(-48.8%)
Dec 2018
$56.16M(+181.9%)
$24.81M(+265.1%)
$54.59M(+1306.1%)
Sep 2018
-
$6.79M(+190.6%)
-$4.53M(-237.8%)
Jun 2018
-
$2.34M(-88.7%)
$3.28M(+342.0%)
Mar 2018
-
$20.65M(+160.2%)
-$1.36M(+98.0%)
Dec 2017
-$68.57M(+43.6%)
-$34.31M(-334.9%)
-$68.57M(-194.6%)
Sep 2017
-
$14.60M(+734.1%)
-$23.28M(+38.6%)
Jun 2017
-
-$2.30M(+95.1%)
-$37.89M(+59.5%)
Mar 2017
-
-$46.56M(-523.8%)
-$93.57M(+23.0%)
Dec 2016
-$121.59M(-688.6%)
$10.99M(>+9900.0%)
-$121.59M(+5.7%)
Sep 2016
-
-$5000.00(+100.0%)
-$128.98M(+11.4%)
Jun 2016
-
-$57.99M(+22.2%)
-$145.50M(-68.2%)
Mar 2016
-
-$74.58M(-2173.5%)
-$86.51M(-461.1%)
Dec 2015
-$15.42M(-12.4%)
$3.60M(+121.8%)
-$15.42M(-79.0%)
Sep 2015
-
-$16.53M(-1740.1%)
-$8.61M(+17.6%)
Jun 2015
-
$1.01M(+128.9%)
-$10.45M(-7.1%)
Mar 2015
-
-$3.49M(-133.6%)
-$9.76M(+28.9%)
Dec 2014
-$13.72M(-141.8%)
$10.40M(+156.6%)
-$13.72M(+49.2%)
Sep 2014
-
-$18.37M(-1179.9%)
-$27.02M(-161.9%)
Jun 2014
-
$1.70M(+122.8%)
-$10.31M(-14.8%)
Mar 2014
-
-$7.46M(-157.6%)
-$8.99M(-58.3%)
Dec 2013
-$5.67M(+78.1%)
-$2.89M(-73.8%)
-$5.67M(+5.9%)
Sep 2013
-
-$1.67M(-155.0%)
-$6.03M(+50.6%)
Jun 2013
-
$3.03M(+173.1%)
-$12.21M(+45.2%)
Mar 2013
-
-$4.15M(-27.7%)
-$22.30M(+13.9%)
Dec 2012
-$25.89M
-$3.25M(+58.6%)
-$25.89M(+23.0%)
Sep 2012
-
-$7.85M(-11.2%)
-$33.65M(+12.6%)
DateAnnualQuarterlyTTM
Jun 2012
-
-$7.06M(+8.9%)
-$38.48M(+15.7%)
Mar 2012
-
-$7.74M(+29.6%)
-$45.64M(+6.1%)
Dec 2011
-$48.59M(-21.0%)
-$11.00M(+13.3%)
-$48.59M(+6.2%)
Sep 2011
-
-$12.69M(+10.7%)
-$51.83M(-3.7%)
Jun 2011
-
-$14.21M(-32.9%)
-$50.00M(-11.9%)
Mar 2011
-
-$10.69M(+24.9%)
-$44.69M(-11.3%)
Dec 2010
-$40.16M(-116.0%)
-$14.24M(-31.1%)
-$40.16M(-25.2%)
Sep 2010
-
-$10.86M(-22.0%)
-$32.07M(-28.6%)
Jun 2010
-
-$8.90M(-44.2%)
-$24.94M(-23.8%)
Mar 2010
-
-$6.17M(-0.3%)
-$20.15M(-8.4%)
Dec 2009
-$18.60M(-14.9%)
-$6.15M(-64.9%)
-$18.60M(-21.5%)
Sep 2009
-
-$3.73M(+9.2%)
-$15.30M(+13.2%)
Jun 2009
-
-$4.11M(+11.0%)
-$17.63M(+3.8%)
Mar 2009
-
-$4.61M(-61.5%)
-$18.32M(-13.2%)
Dec 2008
-$16.19M(-2377.9%)
-$2.86M(+52.8%)
-$16.19M(-34.3%)
Sep 2008
-
-$6.06M(-26.2%)
-$12.06M(-49.4%)
Jun 2008
-
-$4.80M(-93.9%)
-$8.07M(-51.7%)
Mar 2008
-
-$2.47M(-294.1%)
-$5.32M(-848.7%)
Dec 2007
$710.60K(+114.1%)
$1.27M(+161.5%)
$710.50K(+15.5%)
Sep 2007
-
-$2.07M(-1.3%)
$615.40K(-52.9%)
Jun 2007
-
-$2.05M(-157.6%)
$1.31M(+61.4%)
Mar 2007
-
$3.56M(+201.3%)
$809.60K(+116.1%)
Dec 2006
-$5.04M(+39.8%)
$1.18M(+185.4%)
-$5.04M(+32.1%)
Sep 2006
-
-$1.38M(+45.7%)
-$7.41M(+5.0%)
Jun 2006
-
-$2.54M(-11.0%)
-$7.80M(+2.2%)
Mar 2006
-
-$2.29M(-91.2%)
-$7.98M(+4.6%)
Dec 2005
-$8.36M(+20.7%)
-$1.20M(+32.4%)
-$8.37M(+21.8%)
Sep 2005
-
-$1.77M(+34.7%)
-$10.70M(+8.3%)
Jun 2005
-
-$2.72M(-1.5%)
-$11.67M(-2.7%)
Mar 2005
-
-$2.68M(+24.2%)
-$11.36M(-7.7%)
Dec 2004
-$10.55M(-90.7%)
-$3.53M(-29.0%)
-$10.55M(-25.6%)
Sep 2004
-
-$2.74M(-13.7%)
-$8.40M(-15.7%)
Jun 2004
-
-$2.41M(-29.3%)
-$7.26M(-22.5%)
Mar 2004
-
-$1.86M(-34.4%)
-$5.92M(-7.1%)
Dec 2003
-$5.53M(-38.2%)
-$1.39M(+13.3%)
-$5.53M(-23.9%)
Sep 2003
-
-$1.60M(-48.8%)
-$4.47M(-17.6%)
Jun 2003
-
-$1.07M(+27.0%)
-$3.80M(+8.2%)
Mar 2003
-
-$1.47M(-358.6%)
-$4.14M(-3.3%)
Dec 2002
-$4.00M(-109.4%)
-$321.00K(+65.5%)
-$4.00M(+21.0%)
Sep 2002
-
-$929.30K(+34.2%)
-$5.07M(-60.4%)
Jun 2002
-
-$1.41M(-5.6%)
-$3.16M(-28.3%)
Mar 2002
-
-$1.34M(+3.4%)
-$2.46M(-28.8%)
Dec 2001
-$1.91M(+40.2%)
-$1.38M(-241.5%)
-$1.91M(-35.2%)
Sep 2001
-
$978.40K(+236.6%)
-$1.41M(+50.0%)
Jun 2001
-
-$716.50K(+9.1%)
-$2.82M(+20.8%)
Mar 2001
-
-$787.80K(+11.2%)
-$3.57M(-9.7%)
Dec 2000
-$3.19M(-78.2%)
-$886.80K(-105.0%)
-$3.25M(-18.7%)
Sep 2000
-
-$432.60K(+70.3%)
-$2.74M(-18.8%)
Jun 2000
-
-$1.46M(-208.8%)
-$2.31M(-172.3%)
Mar 2000
-
-$472.50K(-26.3%)
-$846.70K(-126.3%)
Dec 1999
-$1.79M(+43.4%)
-
-
Dec 1999
-
-$374.20K
-$374.20K
Dec 1998
-$3.17M
-
-

FAQ

  • What is ANI Pharmaceuticals, Inc. annual free cash flow?
  • What is the all-time high annual free cash flow for ANI Pharmaceuticals, Inc.?
  • What is ANI Pharmaceuticals, Inc. annual free cash flow year-on-year change?
  • What is ANI Pharmaceuticals, Inc. quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for ANI Pharmaceuticals, Inc.?
  • What is ANI Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?
  • What is ANI Pharmaceuticals, Inc. TTM free cash flow?
  • What is the all-time high TTM free cash flow for ANI Pharmaceuticals, Inc.?
  • What is ANI Pharmaceuticals, Inc. TTM free cash flow year-on-year change?

What is ANI Pharmaceuticals, Inc. annual free cash flow?

The current annual free cash flow of ANIP is $47.06M

What is the all-time high annual free cash flow for ANI Pharmaceuticals, Inc.?

ANI Pharmaceuticals, Inc. all-time high annual free cash flow is $100.45M

What is ANI Pharmaceuticals, Inc. annual free cash flow year-on-year change?

Over the past year, ANIP annual free cash flow has changed by -$53.38M (-53.15%)

What is ANI Pharmaceuticals, Inc. quarterly free cash flow?

The current quarterly free cash flow of ANIP is $37.89M

What is the all-time high quarterly free cash flow for ANI Pharmaceuticals, Inc.?

ANI Pharmaceuticals, Inc. all-time high quarterly free cash flow is $68.90M

What is ANI Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?

Over the past year, ANIP quarterly free cash flow has changed by +$30.86M (+438.93%)

What is ANI Pharmaceuticals, Inc. TTM free cash flow?

The current TTM free cash flow of ANIP is $136.04M

What is the all-time high TTM free cash flow for ANI Pharmaceuticals, Inc.?

ANI Pharmaceuticals, Inc. all-time high TTM free cash flow is $136.04M

What is ANI Pharmaceuticals, Inc. TTM free cash flow year-on-year change?

Over the past year, ANIP TTM free cash flow has changed by +$62.39M (+84.72%)
On this page